JPWO2022059776A1 - - Google Patents

Info

Publication number
JPWO2022059776A1
JPWO2022059776A1 JP2022550628A JP2022550628A JPWO2022059776A1 JP WO2022059776 A1 JPWO2022059776 A1 JP WO2022059776A1 JP 2022550628 A JP2022550628 A JP 2022550628A JP 2022550628 A JP2022550628 A JP 2022550628A JP WO2022059776 A1 JPWO2022059776 A1 JP WO2022059776A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022550628A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2022059776A1 publication Critical patent/JPWO2022059776A1/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2022550628A 2020-09-17 2021-09-17 Pending JPWO2022059776A1 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020156460 2020-09-17
PCT/JP2021/034305 WO2022059776A1 (ja) 2020-09-17 2021-09-17 オートファジー活性化剤

Publications (1)

Publication Number Publication Date
JPWO2022059776A1 true JPWO2022059776A1 (ja) 2022-03-24

Family

ID=80776143

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022550628A Pending JPWO2022059776A1 (ja) 2020-09-17 2021-09-17

Country Status (6)

Country Link
US (1) US20230364119A1 (ja)
EP (1) EP4215200A1 (ja)
JP (1) JPWO2022059776A1 (ja)
KR (1) KR20230051237A (ja)
CN (1) CN116600815A (ja)
WO (1) WO2022059776A1 (ja)

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5944375A (ja) 1982-09-06 1984-03-12 Senjiyu Seiyaku Kk α−トコフエロ−ルリン酸エステルの安定な水溶液
US4654869A (en) 1985-09-11 1987-03-31 Itt Corporation Information collecting and forwarding apparatus
JPH0649715B2 (ja) 1987-02-10 1994-06-29 栗田工業株式会社 末端にイノシト−ル残基を結合したグルコオリゴ糖およびその製造方法
JPH0730066B2 (ja) 1988-03-09 1995-04-05 株式会社日本ハイポックス アスコルビン酸誘導体及びアスコルビン酸誘導体からなる抗酸化剤
JP2747001B2 (ja) 1989-04-18 1998-05-06 昭和電工株式会社 Ｌ―アスコルビン酸―２―リン酸エステル類の製造法
JP2926412B2 (ja) 1989-05-19 1999-07-28 株式会社林原生物化学研究所 α―グリコシル―Ｌ―アスコルビン酸とその製造方法並びに用途
JPH05213763A (ja) * 1992-02-10 1993-08-24 Sanwa Kagaku Kenkyusho Co Ltd 易吸収活性化カルシウム製剤
JPH06298783A (ja) 1993-03-31 1994-10-25 Mitsui Toatsu Chem Inc 新規なグリコシドの製造法
JP2705512B2 (ja) 1993-06-04 1998-01-28 昭和電工株式会社 Ｌ−アスコルビン酸−２−リン酸エステルの製造方法
JPH08134055A (ja) 1994-11-08 1996-05-28 Nippon High Potsukusu:Kk ３−ｏ−置換アスコルビン酸の製造方法
JPH0914705A (ja) 1995-06-29 1997-01-17 Hitachi Ltd 流体移送装置
NZ517833A (en) * 1999-08-20 2004-01-30 Ferrosan As Oral delivery of antioxidants vitamin C and vitamin E combinations in slow- and plain-release formulations for treating oxidative stress
US7521481B2 (en) * 2003-02-27 2009-04-21 Mclaurin Joanne Methods of preventing, treating and diagnosing disorders of protein aggregation
WO2013018779A1 (ja) 2011-08-01 2013-02-07 株式会社林原 α－グルコシルヘスペリジンの結晶とその用途
WO2014181716A1 (ja) 2013-05-10 2014-11-13 昭和電工株式会社 糖化反応抑制剤
JPWO2016076310A1 (ja) 2014-11-10 2017-08-17 昭和電工株式会社 保湿剤
CN107847466B (zh) 2015-04-08 2024-02-06 贝欧曼蒂克丝公司 用于调节创伤愈合的配制物和方法
BR112018006873A2 (pt) 2015-10-05 2018-11-06 The Trustees Of Columbia University In The City Of New York ativadores do fluxo autofágico e fosfolipase d e depuração de agregados de proteína incluindo tau e tratamento de proteinopatias
JP7136765B2 (ja) 2017-03-24 2022-09-13 株式会社林原 オートファジー誘導剤とその用途
WO2019045113A1 (ja) 2017-09-04 2019-03-07 昭和電工株式会社 イノシトール誘導体の混合物
JP2019112354A (ja) * 2017-12-25 2019-07-11 昭和電工株式会社 抗炎症剤及び抗炎症用組成物
JP2020156460A (ja) 2019-03-20 2020-10-01 株式会社リコー 液滴吐出装置用の液セット

Also Published As

Publication number Publication date
KR20230051237A (ko) 2023-04-17
EP4215200A1 (en) 2023-07-26
WO2022059776A1 (ja) 2022-03-24
US20230364119A1 (en) 2023-11-16
CN116600815A (zh) 2023-08-15

Similar Documents

Publication Publication Date Title
BR112023012656A2 (ja)
JPWO2022059775A1 (ja)
BR102021015500A2 (ja)
BR112022009896A2 (ja)
BR102021007058A2 (ja)
JPWO2021177335A1 (ja)
BR102020022030A2 (ja)
BR112023011738A2 (ja)
BR112023016292A2 (ja)
BR112023011610A2 (ja)
BR112023011539A2 (ja)
BR112023008976A2 (ja)
BR112023009656A2 (ja)
BR112023006729A2 (ja)
JPWO2022059767A1 (ja)
JPWO2022059776A1 (ja)
BR102021017576A2 (ja)
BR102021016837A2 (ja)
BR102021016551A2 (ja)
BR102021016176A2 (ja)
BR102021016200A2 (ja)
BR102021015566A2 (ja)
BR102021015450A8 (ja)
BR102021015247A2 (ja)
BR102021015220A2 (ja)